Latest Articles
Ocean Grove woman’s cancer fight a ‘shock to the system’ - Geelong Advertiser
Ocean Grove woman’s cancer fight a ‘shock to the system’ Geelong Advertiser
Published: Feb. 9, 2024, 8 a.m.
FDA Approves GSK's Jemperli For Expanded Use In Endometrial Cancer - Contract Pharma
FDA Approves GSK's Jemperli For Expanded Use In Endometrial Cancer Contract Pharma
Published: Feb. 8, 2024, 8 a.m.
World Cancer Day 2024: 5 common cancers in women beyond cervical cancer - Hindustan Times
World Cancer Day 2024: 5 common cancers in women beyond cervical cancer Hindustan Times
Published: Feb. 4, 2024, 8 a.m.
HER2 ADCs in Endometrial Cancer: Shaping the Treatment Landscape - OncLive
HER2 ADCs in Endometrial Cancer: Shaping the Treatment Landscape OncLive
Published: Feb. 1, 2024, 8 a.m.
Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer - OncLive
Dr Krause on GLP-1 Receptor Agonist Therapy in Endometrial Cancer OncLive
Published: Jan. 26, 2024, 8 a.m.
Gynecologic cancers: Early detection and understanding symptoms can save lives - University of Alabama at Birmingham
Gynecologic cancers: Early detection and understanding symptoms can save lives University of Alabama at Birmingham
Published: Jan. 26, 2024, 8 a.m.
Cancer diagnosis inspired Wiltshire event that led to award nomination - BBC
Cancer diagnosis inspired Wiltshire event that led to award nomination BBC
Published: Jan. 26, 2024, 8 a.m.
Bristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal cancer subset - FiercePharma
Bristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal cancer subset FiercePharma
Published: Jan. 20, 2024, 8 a.m.
The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway | Cell Death & Disease - Nature.com
The P286R mutation of DNA polymerase ε activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway | Cell Death & Disease Nature.com
Published: Jan. 18, 2024, 8 a.m.
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer - Nature.com
Phosphorylation of INF2 by AMPK promotes mitochondrial fission and oncogenic function in endometrial cancer Nature.com
Published: Jan. 17, 2024, 8 a.m.
Link copied to clipboard!